Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Noon World Inc. maintains a focused presence in the Biotechnology & Pharmaceuticals technology area, with its current prosecution activity limited to 1 pending office action. This matter is assigned to 1 distinct examiner, WESTERBERG, NISSA M, who also represents the 1 distinct art unit involved in the company's current filings. The alignment of 1 pending office action with 1 distinct examiner and 1 distinct art unit indicates a highly specialized or early-stage portfolio.
As the busiest examiner with 1 busiest examiner pending action, WESTERBERG, NISSA M holds the entirety of the company's pending workload. This concentration suggests a singular point of interaction within the patent office, where the prosecution outcome relies on a specific individual's review. Practitioners can expect a direct line of communication but must also account for the lack of diversity in examiner perspectives. This streamlined profile is typical for entities with very specific technical goals in the biotechnology sector, where every current data point converges on a single examiner and a single technical classification.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WESTERBERG, NISSA M | 1 | 23.4% | +37.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19376049 | COMPOSITIONS AND METHODS FOR NUTRACEUTICAL GUMMY | WESTERBERG, NISSA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19376049 | COMPOSITIONS AND METHODS FOR NUTRACEUTICAL GUMMY | WESTERBERG, NISSA M | — |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19376049 | COMPOSITIONS AND METHODS FOR NUTRACEUTICAL GUMMY | WESTERBERG, NISSA M | 1618 | §103§112 | Final Rejection | — | Pending | Oct 31, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial